End-user scientists and engineers fear the complexity of running jobs in HPC. But there are software tool-kits available to help, as Tom Wilkie discovers
The era of data-centric HPC is upon us. Robert Roe investigates how data storage companies are rising to the challenge
The way Europe has joined up its networks not only supports supercomputing on the continent, but also offers a model for international cooperation that might have lessons for the development of next-generation technology, as Tom Wilkie discovers
Lindsay Botten and Neil Stringfellow explain how Australia has developed a national HPC strategy to address the countrys unique challenges in science, climate, and economic development
John Barr surveys the technologies that will underpin the next generation of HPC processors and finds that software, not hardware, holds the key.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
